COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention
A Sharma, I Ahmad Farouk, SK Lal - Viruses, 2021 - mdpi.com
Three major outbreaks of the coronavirus, a zoonotic virus known to cause respiratory
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …
Environmental perspective of COVID-19
The outbreak of COVID-19 has caused concerns globally. On 30 January WHO has
declared it as a global health emergency. The easy spread of this virus made people to wear …
declared it as a global health emergency. The easy spread of this virus made people to wear …
Structure of replicating SARS-CoV-2 polymerase
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses
an RNA-dependent RNA polymerase (RdRp) for the replication of its genome and the …
an RNA-dependent RNA polymerase (RdRp) for the replication of its genome and the …
Wuhan to world: the COVID-19 pandemic
COVID-19 is a Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV-2, a
novel virus which belongs to the family Coronaviridae. It was first reported in December …
novel virus which belongs to the family Coronaviridae. It was first reported in December …
A brief review of socio-economic and environmental impact of Covid-19
In recent months, Covid-19 has caused significant global social and economic distress.
Governments and health officials around the world have introduced mandatory preventive …
Governments and health officials around the world have introduced mandatory preventive …
SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19)
A Ruiz-Bravo, M Jiménez-Valera - Ars Pharmaceutica (Internet), 2020 - SciELO Espana
Método: Se examinaron las publicaciones más relevantes en relación con los objetivos de
la revisión. Resultados: La enfermedad, conocida como COVID-19, cursa con tos, fiebre y …
la revisión. Resultados: La enfermedad, conocida como COVID-19, cursa con tos, fiebre y …
[HTML][HTML] COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics
SA Azer - New Microbes and New Infections, 2020 - Elsevier
Abstract The novel coronavirus (COVID-19) outbreak started early in December 2019 in the
Hubei province and its capital Wuhan of the People's Republic of China and caused a …
Hubei province and its capital Wuhan of the People's Republic of China and caused a …
[HTML][HTML] Efficacy and safety of COVID-19 vaccines: a systematic review
X Kai, TU Xiao-Yan, LIU Miao, ZW Liang… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
Methods PubMed, Embase, Cochrane Library, Clinicaltrial. gov, CNKI, Wanfang Data, China
Biomedical Literature Service System, and China Clinical Trial Registry were searched for …
Biomedical Literature Service System, and China Clinical Trial Registry were searched for …
Coronavirus disease (COVID-19): Current status and prospects for drug and vaccine development
K Ita - Archives of medical research, 2021 - Elsevier
The Coronavirus disease 2019 (COVID-19) pandemic has spread to almost all nooks and
corners of the world. There are numerous potential approaches to pharmacologically fight …
corners of the world. There are numerous potential approaches to pharmacologically fight …
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
S Keretsu, SP Bhujbal, SJ Cho - Scientific reports, 2020 - nature.com
In the rapidly evolving coronavirus disease (COVID-19) pandemic, repurposing existing
drugs and evaluating commercially available inhibitors against druggable targets of the virus …
drugs and evaluating commercially available inhibitors against druggable targets of the virus …